Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ANAB AnaptysBio, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $53.89 -2.1% | $15.02 -2.3% |
| StockIQ Score | 48D+ Moderate Risk: Medium | 35F Weak Risk: High |
| Technical | 26F | 13F |
| Fundamental | 43D | 35F |
| Growth | 82A- | 50C- |
| Fair Value | 38F | 38F |
| News | 68B- | 50C- |
| Quality | 58C | 50C- |
| Risk | 48D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
AnaptysBio (ANAB) outperforms Ascentage Pharma (AAPG) in nearly every category. Its investor, technical, and growth scores are significantly higher—54 vs. 37, 53 vs. 18, and 82 vs. 50—showing stronger market confidence, stability, and expansion potential. Both share the same valuation score of 38, but ANAB’s overall "MODERATE" rating contrasts with AAPG’s "WEAK," reflecting broader strength.